Effects of inflammation on bone: an update

被引:49
作者
Baker-LePain, Julie C.
Nakamura, Mary C. [2 ,3 ]
Lane, Nancy E. [1 ]
机构
[1] Univ Calif Davis, Med Ctr, Dept Internal Med, Ctr Healthy Aging, Sacramento, CA 95817 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] San Francisco VA Med Ctr, San Francisco, CA USA
关键词
BMP pathway; bone loss; cytokine; inflammation; osteoblast; osteoclast; therapy; WNT pathway; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; MINERAL-DENSITY; TNF-ALPHA; RHEUMATOID-ARTHRITIS; RADIOGRAPHIC PROGRESSION; DOUBLE-BLIND; ANKYLOSING-SPONDYLITIS; OSTEOCLAST FORMATION;
D O I
10.1097/BOR.0b013e3283474dbe
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review To present an updated summary of the relationship between inflammation and localized and generalized bone loss in the rheumatic diseases. Recent findings In addition to the well established role of inflammatory cytokines in promoting enhanced osteoclast function and bone loss, recent work has discovered the cytokine milieu may also inhibit osteoblast function and bone repair. The WNT and bone morphogenetic protein pathways provide molecular links between inflammation and altered bone homeostasis in chronic inflammatory states. These pathways and others have been the targets of emerging therapies for the management of inflammatory bone loss. Summary Inflammation and bone loss are linked through a number of molecular pathways. Both of these processes need to be addressed when designing an effective treatment strategy for the rheumatic diseases.
引用
收藏
页码:389 / 395
页数:7
相关论文
共 79 条
[1]   MECHANISMS OF DISEASE Inflammatory Bowel Disease [J].
Abraham, Clara ;
Cho, Judy H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) :2066-2078
[2]   Altered Skeletal Expression of Sclerostin and Its Link to Radiographic Progression in Ankylosing Spondylitis [J].
Appel, Heiner ;
Ruiz-Heiland, Gisela ;
Listing, Joachim ;
Zwerina, Jochen ;
Herrmann, Martin ;
Mueller, Ruediger ;
Haibel, Hildrun ;
Baraliakos, Xenofon ;
Hempfing, Axel ;
Rudwaleit, Martin ;
Sieper, Joachim ;
Schett, Georg .
ARTHRITIS AND RHEUMATISM, 2009, 60 (11) :3257-3262
[3]   Assessment of bone remodelling in childhood-onset systemic lupus erythematosus [J].
Baker-LePain, Julie C. ;
Nakamura, Mary C. ;
Shepherd, John ;
von Scheven, Emily .
RHEUMATOLOGY, 2011, 50 (03) :611-619
[4]   A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J].
Bathon, JM ;
Martin, RW ;
Fleischmann, RM ;
Tesser, JR ;
Schiff, MH ;
Keystone, EC ;
Genovese, MC ;
Wasko, MC ;
Moreland, LW ;
Weaver, AL ;
Markenson, J ;
Finck, BK .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1586-1593
[5]   High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[6]   Evidence that cytokines play a role in rheumatoid arthritis [J].
Brennan, Fionula M. ;
McInnes, Iain B. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (11) :3537-3545
[7]   Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus [J].
Bultink, IEM ;
Lems, WF ;
Kostense, PJ ;
Dijkmans, BAC ;
Voskuyl, AE .
ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :2044-2050
[8]   SKELETAL TISSUE AND TRANSFORMING GROWTH FACTOR-BETA [J].
CENTRELLA, M ;
MCCARTHY, TL ;
CANALIS, E .
FASEB JOURNAL, 1988, 2 (15) :3066-3073
[9]   Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis [J].
Chopin, F. ;
Garnero, P. ;
le Henanff, A. ;
Debiais, F. ;
Daragon, A. ;
Roux, C. ;
Sany, J. ;
Wendling, D. ;
Zarnitsky, C. ;
Ravaud, P. ;
Thomas, T. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) :353-357
[10]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480